THALAGEN Trademark

Trademark Overview

On Wednesday, November 16, 2005, a trademark application was filed for THALAGEN with the United States Patent and Trademark Office. The USPTO has given the THALAGEN trademark a serial number of 78755226. The federal status of this trademark filing is ABANDONED - EXPRESS AFTER PUB as of Monday, June 14, 2010. This trademark is owned by Errant Gene Therapeutics, LLC. The THALAGEN trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical products and preparations in the form of a suspension intravenously administered to the patients for the treatment of thalassemia and sickle cell anemia, for use in connection with bone marrow transplants
thalagen

General Information

Serial Number78755226
Word MarkTHALAGEN
Filing DateWednesday, November 16, 2005
Status605 - ABANDONED - EXPRESS AFTER PUB
Status DateMonday, June 14, 2010
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, July 25, 2006

Trademark Statements

Goods and ServicesPharmaceutical products and preparations in the form of a suspension intravenously administered to the patients for the treatment of thalassemia and sickle cell anemia, for use in connection with bone marrow transplants

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code8 - Abandoned
Class Status DateMonday, June 14, 2010
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameErrant Gene Therapeutics, LLC
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressChicago, IL 60661
Party NameErrant Gene Therapeutics, LLC
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressChicago, IL 60606

Trademark Events

Event DateEvent Description
Monday, June 14, 2010ABANDONMENT NOTICE MAILED - AFTER PUBLICATION
Monday, June 14, 2010ABANDONMENT - AFTER PUBLICATION
Friday, June 11, 2010TEAS EXPRESS ABANDONMENT RECEIVED
Monday, June 7, 2010TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, June 7, 2010TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, December 14, 2009EXTENSION 5 GRANTED
Thursday, December 10, 2009EXTENSION 5 FILED
Thursday, December 10, 2009TEAS EXTENSION RECEIVED
Thursday, March 12, 2009EXTENSION 4 GRANTED
Tuesday, March 10, 2009EXTENSION 4 FILED
Tuesday, March 10, 2009TEAS EXTENSION RECEIVED
Friday, December 19, 2008EXTENSION 3 GRANTED
Friday, December 5, 2008EXTENSION 3 FILED
Thursday, December 18, 2008CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, December 5, 2008TEAS EXTENSION RECEIVED
Tuesday, July 1, 2008TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, June 16, 2008EXTENSION 2 GRANTED
Tuesday, June 10, 2008EXTENSION 2 FILED
Tuesday, June 10, 2008TEAS EXTENSION RECEIVED
Friday, January 4, 2008EXTENSION 1 GRANTED
Tuesday, December 11, 2007EXTENSION 1 FILED
Tuesday, December 11, 2007TEAS EXTENSION RECEIVED
Wednesday, June 20, 2007UNDELIVERABLE MAIL - CORRESP. REMAILED
Tuesday, June 12, 2007NOA MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, February 6, 2007EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
Thursday, December 7, 2006CHANGES/CORRECTIONS AFTER PUB APPROVAL ENTERED
Thursday, December 7, 2006ASSIGNED TO PETITION STAFF
Tuesday, November 21, 2006PAPER RECEIVED
Wednesday, August 16, 2006EXTENSION OF TIME TO OPPOSE RECEIVED
Tuesday, July 25, 2006PUBLISHED FOR OPPOSITION
Wednesday, July 5, 2006NOTICE OF PUBLICATION
Tuesday, June 6, 2006LAW OFFICE PUBLICATION REVIEW COMPLETED
Friday, June 2, 2006ASSIGNED TO LIE
Tuesday, May 30, 2006APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, May 22, 2006ASSIGNED TO EXAMINER
Tuesday, November 22, 2005NEW APPLICATION ENTERED IN TRAM

Related Keywords

thalagen anemia cell sickle connection bone transplants marrow thalassemia treatment form